The meeting "In Vivo and Transgenic Models" in which TRANS GENIC is participating is a meeting in which companies dealing with transgenic models take part, and has been held for two days.

TRANS GENIC has been providing genetic function data based on phenotype of analysis of gene knockout mice to mainly domestic markets such as domestic pharmaceutical companies. In addition, with the aim of finding new markets in Europe, TRANS GENIC is giving a poster presentation about the guideline of our business and will present more about it.

On Sep. 17, Prof. Yamamura, who is a non-executive director of TRANS GENIC is giving a presentation about "Desirable alterations of the genome in mice for drug discovery by the exchangeable gene trap method."

About "In Vivo and Transgenic Models" (English Only)